Cargando…
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
AIM: To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). METHODS: Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with (n = 32) or without (n = 11) concomitant in...
Autores principales: | Bajer, Lukas, Kverka, Miloslav, Kostovcik, Martin, Macinga, Peter, Dvorak, Jiri, Stehlikova, Zuzana, Brezina, Jan, Wohl, Pavel, Spicak, Julius, Drastich, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504370/ https://www.ncbi.nlm.nih.gov/pubmed/28740343 http://dx.doi.org/10.3748/wjg.v23.i25.4548 |
Ejemplares similares
-
Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018) -
Su1497: EFFECT OF SARS COV-2 VACCINE IN IBD PATIENTS ON BIOLOGIC THERAPY INCLUDING LIVER TRANSPLANT RECIPIENTS.
por: Brezina, Jan, et al.
Publicado: (2022) -
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
por: Březina, Jan, et al.
Publicado: (2021) -
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
por: Coufal, Stepan, et al.
Publicado: (2019) -
Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
por: Schierová, Dagmar, et al.
Publicado: (2020)